Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Simulect shows good results in pediatric transplant recipients

Aug. 31, 2000

KS Biomedix forms collaboration with Eukarion

Aug. 31, 2000

Viral protein products reduce transplant rejection in preclinical study

Aug. 30, 2000

Novartis updates transplantation pipeline at ongoing congress

Aug. 30, 2000

Tablet form of Rapamune receives FDA approval

Aug. 30, 2000

Active Biotech updates agreements for traveler's diarrhea vaccines

Aug. 28, 2000

Pteridine derivatives reported by K.U. Leuven as treatment for autoimmune disorders

Aug. 25, 2000

Naked DNA malaria vaccine phase II clinical trial commences

Aug. 25, 2000

Altea Genomics and Elan to jointly develop DNA vaccines

Aug. 24, 2000

Antex Biologics signs CRADA with U.S. Navy for Campylobacter vaccine

Aug. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...